| Study ID
|
1517-CL-0613
|
| Study Title
|
A Phase 3, Randomized, Open-Label, Active-Controlled Study
to Evaluate the Efficacy and Safety of Roxadustat in the
Maintenance Treatment of Anemia in End Stage Renal
Disease Subjects on Stable Dialysis
|
| Clinicaltrials.gov Identifier
|
NCT02278341
|
| Compound Name
|
ASP1517 / roxadustat
|
| Medical Indication or Disease
|
Anemia with chronic kidney disease
|
| Study Sponsor
|
|
| Collaborator
|
FibroGen
|
| Study Start Date
|
21-Nov-2014
|
| Study Completion Date
|
06-Jul-2018
|
| Clinical Study Result
|
|
Select the language
|
|
|
|
|
|
| Plain Language Summary
|
|
Select the language
|
|
|
|
|
|